A New Kind Of Pipeline: The Business Model Innovation Pipeline
Executive Summary
NEW YORK-If the business model for the pharmaceutical industry is not yet broken, it is on its way, and companies need to think outside the box and employ innovative strategies to build new models, key speakers told FDC/Windhover's Pharmaceutical Strategic Alliances Conference in New York CityYou may also be interested in...
PSA: What We Have Here Is A Failure to Innovate
Waking the Giant: Business Model Innovation in the Drug Industry
Finding a Way Out of Pharma's Dealmaking Dilemma
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: